Anhui Hongyu Wuzhou Medical Manufacturer Co.,LTD. (SHE:301234)
China · Delayed Price · Currency is CNY 40.65
-0.07 (-0.17%)
At close: Feb 13, 2026
SHE:301234 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 480.05 | 477.23 | 533.5 | 546.78 | 512.79 | 471.15 |
Other Revenue | 0.2 | 0.2 | 0.18 | 0.33 | 0.18 | 0.09 |
| 480.25 | 477.43 | 533.68 | 547.11 | 512.96 | 471.24 | |
Revenue Growth (YoY) | 4.04% | -10.54% | -2.46% | 6.66% | 8.85% | -3.23% |
Cost of Revenue | 408.72 | 395.53 | 422.68 | 428.74 | 399.7 | 376.45 |
Gross Profit | 71.53 | 81.9 | 111 | 118.38 | 113.26 | 94.79 |
Selling, General & Admin | 38.35 | 33.06 | 35.25 | 43.31 | 19.93 | 19.18 |
Research & Development | 10.27 | 12.97 | 13.48 | 13.09 | 11.78 | 10.02 |
Other Operating Expenses | 8.76 | 1.54 | 1.56 | 1.82 | 2.6 | 2.09 |
Operating Expenses | 57.12 | 49.35 | 53.43 | 63.13 | 35.07 | 31.27 |
Operating Income | 14.42 | 32.55 | 57.56 | 55.25 | 78.19 | 63.51 |
Interest Expense | -0.03 | -0.02 | -0.01 | -0.63 | -1.03 | -1.06 |
Interest & Investment Income | 5.7 | 5.69 | 8.72 | 2.11 | 2.29 | 1.99 |
Currency Exchange Gain (Loss) | 5.66 | 5.66 | 3.56 | 7.06 | -2.49 | -7.8 |
Other Non Operating Income (Expenses) | -1.38 | -0.91 | -1.37 | -0.65 | -0.81 | -0.48 |
EBT Excluding Unusual Items | 24.37 | 42.97 | 68.46 | 63.14 | 76.15 | 56.16 |
Gain (Loss) on Sale of Investments | 0.84 | 0.9 | -1.34 | -6.15 | - | 7.15 |
Gain (Loss) on Sale of Assets | -0.17 | 0.01 | - | - | -0.47 | - |
Asset Writedown | 0.45 | -0.32 | -0.47 | -1.94 | -0.01 | - |
Other Unusual Items | 3.81 | 2.89 | 4.29 | 18.4 | 4.17 | 5.29 |
Pretax Income | 29.29 | 46.45 | 70.94 | 73.45 | 79.84 | 68.6 |
Income Tax Expense | 5.14 | 6.49 | 10.67 | 2.52 | 11.45 | 11.86 |
Net Income | 24.14 | 39.97 | 60.27 | 70.93 | 68.39 | 56.74 |
Net Income to Common | 24.14 | 39.97 | 60.27 | 70.93 | 68.39 | 56.74 |
Net Income Growth | -40.47% | -33.68% | -15.04% | 3.71% | 20.53% | 7.27% |
Shares Outstanding (Basic) | 68 | 68 | 68 | 60 | 51 | 51 |
Shares Outstanding (Diluted) | 68 | 68 | 68 | 60 | 51 | 51 |
Shares Change (YoY) | -0.01% | 0.00% | 14.28% | 16.66% | -0.24% | 0.50% |
EPS (Basic) | 0.36 | 0.59 | 0.89 | 1.19 | 1.34 | 1.11 |
EPS (Diluted) | 0.36 | 0.59 | 0.89 | 1.19 | 1.34 | 1.11 |
EPS Growth | -40.46% | -33.68% | -25.65% | -11.10% | 20.81% | 6.73% |
Free Cash Flow | 56.67 | 51.9 | 10.92 | -52.51 | 6.07 | 21.31 |
Free Cash Flow Per Share | 0.83 | 0.76 | 0.16 | -0.88 | 0.12 | 0.42 |
Dividend Per Share | 0.300 | 0.300 | 0.400 | 0.500 | - | - |
Dividend Growth | -25.00% | -25.00% | -20.00% | - | - | - |
Gross Margin | 14.89% | 17.16% | 20.80% | 21.64% | 22.08% | 20.11% |
Operating Margin | 3.00% | 6.82% | 10.79% | 10.10% | 15.24% | 13.48% |
Profit Margin | 5.03% | 8.37% | 11.29% | 12.96% | 13.33% | 12.04% |
Free Cash Flow Margin | 11.80% | 10.87% | 2.04% | -9.60% | 1.18% | 4.52% |
EBITDA | 57.5 | 70.13 | 87.81 | 77.7 | 96.36 | 77.12 |
EBITDA Margin | 11.97% | 14.69% | 16.45% | 14.20% | 18.79% | 16.36% |
D&A For EBITDA | 43.08 | 37.58 | 30.25 | 22.45 | 18.17 | 13.61 |
EBIT | 14.42 | 32.55 | 57.56 | 55.25 | 78.19 | 63.51 |
EBIT Margin | 3.00% | 6.82% | 10.79% | 10.10% | 15.24% | 13.48% |
Effective Tax Rate | 17.56% | 13.96% | 15.05% | 3.43% | 14.34% | 17.28% |
Revenue as Reported | 480.25 | 477.43 | 533.68 | 547.11 | 512.96 | 471.24 |
Advertising Expenses | - | 1.65 | 1.44 | 0.78 | 0.66 | 0.26 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.